Healthy Lids For Life

Ending Dry Eye by Addressing Its Root Cause

Meibum Scientific addresses the biological mechanism driving chronic dry eye disease through a protocolized platform that removes intraglandular biofilm — the missing treatment target in meibomian gland dysfunction.

Learn More View Products →

Clinician-led

Science-backed

Root-cause framing

Dry Eye Is a Disease of Gland Failure

Chronic dry eye is driven primarily by meibomian gland dysfunction (MGD), a progressive condition in which obstruction and inflammation impair the eye’s ability to produce a stable tear film.

Obstruction builds

Blockage prevents normal oil flow, destabilizing the tear film and increasing evaporation. Inflammation escalates.

Inflammation escalates

Irritation and inflammation accelerate dysfunction, worsening symptoms over time. Glands can atrophy.

Glands can atrophy

Without addressing the underlying driver, gland structure can deteriorate and become increasingly difficult to restore.

Tear film stability

What’s happening

Glands obstruct

Oil can’t express normally

Tear film thins

Evaporation increases

Symptoms worsen

Dryness, burning, fluctuating vision

Treating symptoms alone may help temporarily, but stability improves when the underlying driver is addressed.

Why Current Therapies Fail

Temporary relief persists while gland damage continues.

Drops and hygiene

Lubricate the ocular surface but do not address gland obstruction.

Drops and hygiene

Lubricate the ocular surface but do not address gland obstruction.

Heat, expression, and IPL

May provide transient symptomatic relief without removing adherent intraglandular pathology.

Heat, expression, and IPL

May provide transient symptomatic relief without removing adherent intraglandular pathology.

Pharmaceuticals

Reduce inflammation but do not penetrate or remove intraglandular biofilm.

Pharmaceuticals

Reduce inflammation but do not penetrate or remove intraglandular biofilm.

An Unmet Need

Dry eye disease

Dry eye disease (DED) affects millions globally and is one of the leading reasons for eye care visits.

95% of DED

Up to approximately 85–95% of dry eye cases are associated with meibomian gland dysfunction (MGD), contributing to persistent symptoms such as irritation, burning, blurred vision, and discomfort.

Symptom management

Current market solutions focus primarily on symptom management rather than eliminating the underlying cause of disease progression.

Dry Eye Is a Disease of Gland Failure